Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.
about
Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusionRetinal vein occlusion: pathophysiology and treatment optionsNeuroinflammatory responses in diabetic retinopathyAttenuation of corneal neovascularization by topical low-molecular-weight heparin-taurocholate 7 without bleeding complicationRETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION.Evolving European guidance on the medical management of neovascular age related macular degeneration.Pharmacotherapies for diabetic retinopathy: present and future.Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalitiesA reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit.Application of intravitreal bevacizumab for circumscribed choroidal hemangioma.Effects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathyAssociation of fluorescein angiographic features with visual acuity and with optical coherence tomographic and stereoscopic color fundus photographic features of diabetic macular edema in a randomized clinical trialAnti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsisComparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusionLong-term effect of early intervention with single intravitreal injection of bevacizumab followed by panretinal and macular grid photocoagulation in central retinal vein occlusion (CRVO) with macular edema: a pilot study.Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseasesEffect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbitsIntravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results.Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion.Bevacizumab therapy for macular edema in central retinal vein occlusion: Long-term results.A prospective, randomized comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab (avastin) in diffuse diabetic macular edema.The expanding role of vascular endothelial growth factor inhibitors in ophthalmology.Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study.Accelerating repaired basement membrane after bevacizumab treatment on alkali-burned mouse cornea.Changes in the retinal vascular network morphology (diameter and tortuosity) after administration of intravitreal bevacizumab in a patient with ischaemic branch retinal vein occlusion.Pretreatment clinical variables associated with the response to intravitreal bevacizumab (Avastin) injection in patients with persistent diabetic macular edema.Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis)Retinal vein occlusion and macular edema - critical evaluation of the clinical value of ranibizumab.Effect of posterior sub-tenon triamcinolone in macular edema due to non-ischemic vein occlusions.Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion.Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion.Intravitreal bevacizumab alone or combined with macular laser photocoagulation for recurrent or persistent macular edema secondary to branch retinal vein occlusion.Macular hole formation following intravitreal injection of ranibizumab for branch retinal vein occlusion: a case report.Effects of bevacizumab on retinal function in isolated vertebrate retina.Some ethical considerations for the "off-label" use of drugs such as AvastinThe International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.Vascular endothelial growth factor biology: clinical implications for ocular treatmentsIntravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.Intravitreal triamcinolone for acute branch retinal vein occlusion: a randomized clinical trial.The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.
P2860
Q24234625-111E28DC-BFD1-4134-BB41-307D956A796DQ24596993-CAA9E4E8-C1A8-4C29-B7C5-A9D9FAAA48E6Q26798351-E4DE5830-3EFB-4659-9E7D-8D219879A634Q28829757-C9C45C2C-1FD4-47D3-84B1-D3E83B835FB0Q30490830-D34D700C-E419-4DA9-8FC4-529F58141CBAQ33255038-4A7E2856-02AC-437D-BEAE-3B236FBED40FQ33294882-A3DEFEB4-5278-4D81-A2B9-FD35B38D30A9Q33320830-09166435-A128-48BC-BB79-E4ABCD0180D1Q33358094-6CBF7FEE-E181-4CBF-BEFF-2C9DE3473CA8Q33476808-E9F305EB-897B-45BD-8E14-2159F7CB8A7DQ33521675-23F90332-38B4-4160-93F3-B755D2418DE4Q33655961-1A220A4F-4E2F-4B89-8F40-C11A46747DB7Q33750051-C753131C-9F00-4004-AD10-B8CF96795CF7Q33771437-A1B47408-8BB3-4B50-AC09-52143C4F325DQ33816973-076CD106-84D1-4E78-8C1A-61CF1B984FE7Q33840787-73E43A85-E717-4779-BCE8-7895D8936C84Q33911625-73CF8642-FE19-4E34-963A-F6257DA4D5C5Q33959122-7075E76B-D324-41AF-B619-479C4633CD62Q33993712-3090668E-BCED-471A-9F0C-96A78B760F66Q33999888-6355630F-0342-4A29-8918-7105245B1ABCQ34107543-3983655F-384A-4DCB-8930-3BC234101525Q34115840-07DF5821-1363-4A4E-B446-29C32AC3921CQ34601246-532825D7-A81B-4078-B4A8-3E1AC0F52CBEQ34686306-344C5825-A1D3-4280-8F47-362A1BE2686CQ34792088-9CFAA6BD-8F0B-4942-82EF-25E85DBE6A98Q34957852-500E1EF5-D792-4ABF-AD0D-7161E060320EQ35016867-80C66988-80C3-4045-A7E9-DF06F20F6E6FQ35089799-E0CC2B25-64A4-4FC6-8CD1-BBCEEA959211Q35097904-71920594-2588-4E55-B924-B3E8F80723FAQ35098562-560F402F-F002-407F-9F00-CD69F64CFF0DQ35122731-9EEAFA0D-302B-4657-8492-5EF0E47CAE12Q35223263-54FCF1A5-9A31-4FE8-905A-E8548AB5B352Q35749140-58A62BCA-B0CB-4BB6-B677-D80BE8E4EEF4Q35762423-44CDA30D-D51C-423B-895A-11B4ECADA093Q35762558-D524D251-1DC8-479B-898B-9F80F4A0D7F1Q35762657-97488B2A-7061-4694-9EC1-D42B4D090525Q35762769-F4D58792-014C-4CFA-8DA4-BE6A4C261E4DQ35763028-6EA4A12D-3B74-4D99-A0E4-3B7846E7F0F8Q35835522-C514EE1E-82A0-46C5-92A4-1609D3588FECQ35953759-E3155CCE-45DC-4C56-8AF6-4AC21D0B0048
P2860
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Optical coherence tomography f ...... entral retinal vein occlusion.
@ast
Optical coherence tomography f ...... entral retinal vein occlusion.
@en
type
label
Optical coherence tomography f ...... entral retinal vein occlusion.
@ast
Optical coherence tomography f ...... entral retinal vein occlusion.
@en
prefLabel
Optical coherence tomography f ...... entral retinal vein occlusion.
@ast
Optical coherence tomography f ...... entral retinal vein occlusion.
@en
P2093
P1476
Optical coherence tomography f ...... entral retinal vein occlusion.
@en
P2093
Anne E Fung
Carmen A Puliafito
Philip J Rosenfeld
P304
P577
2005-07-01T00:00:00Z